United States · Series C startup
Funding summaryUpdated 26 Oct 2026
$247Mraised across 7 rounds since 2023, from 7 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recorded
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
Beacon Therapeutics filed 9 raises, $221M in all. Filings say how much was sold and to how many investors; they never name the investors.
From Beacon Therapeutics's own website: 6 on the team.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Goldman Sachs
Forbion Capital Partners
TCG
Oxford Science Enterprises
TCG CrossoverMissing a round, or an investor who was in one? Tell us.
Beacon Therapeutics's investors include Goldman Sachs, Forbion Capital Partners, TCG, Oxford Science Enterprises and TCG Crossover.
Beacon Therapeutics has raised $247M across 7 rounds since 2023.
Beacon Therapeutics's most recent round was a Series C of $75M in Jan 2026.
Its most recent round, $75M in Jan 2026, is also its largest on record.
Beacon Therapeutics's first round on record, in Jan 2026, was backed by Goldman Sachs, Forbion Capital Partners and TCG and 2 others.
Beacon Therapeutics's latest named round is a Series C, in Jan 2026.
Beacon Therapeutics is based in the United States.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
